Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:

Caremark PCS Merger Wins Big Customer; Blues Move FEP Mail From Medco

  • News

Executive Summary

Caremark will take over the mail service pharmacy program for the Blue Cross/Blue Shield Association Federal Employees Program effective Jan. 1

You may also be interested in...



CVS Caremark Integration Focuses On PBM/Retail Services For Health Plans

The integration team handling CVS' merger with pharmacy benefit manager Caremark is focusing on the development of new products and services across both the PBM and retail businesses as part of its contract negotiations with health plans, Chief Executive Officer Tom Ryan said

CVS Caremark Integration Focuses On PBM/Retail Services For Health Plans

The integration team handling CVS' merger with pharmacy benefit manager Caremark is focusing on the development of new products and services across both the PBM and retail businesses as part of its contract negotiations with health plans, Chief Executive Officer Tom Ryan said

Blues Association Planning Part D Offering For Federal Workers In 2007

The BlueCross BlueShield Association expects to sponsor a Medicare Part D plan within the Federal Employees Health Benefits Program in 2007

Table

View full table

Related Content

Pink Sheet
Pink Sheet
Pink Sheet
Pink Sheet
Pink Sheet
Tags:
Latest Headlines

Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa

Partisan Politics Returns To US FDA Congressional Oversight

GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows

Pink Sheet Podcast: Leqembi Spending, Woodcock’s Next Act, Pneumococcal Vaccine Development

See All
UsernamePublicRestriction

Register

PS043371

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By